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A report of the annual meeting of the European Society of
Human Genetics, Amsterdam, 6-9 May 2006. 
More than 1,700 human geneticists from 59 countries
congregated in Amsterdam in May for this year’s meeting of
the European Society of Human Genetics, which mainly
focused on the use of post-genome analysis tools to dissect
the causes of and mechanisms governing complex traits.
Many of the exciting studies presented were based on two
technologies: array-based methods for genome-wide geno-
typing or technologies for high-density comparative genome
hybridization (CGH). A highlight of the meeting was the
keynote lecture by Nobel laureate Sydney Brenner (Salk
Institute for Biological Studies, La Jolla, USA) on ‘humani-
ty’s genes’, which focused on the challenges we face in trans-
forming the information from the human genome into
concrete benefits for our societies.
Whole-genome association studies of complex
phenotypes
This year has seen the success of several whole-genome
association studies using genotyping for single-nucleotide
polymorphisms (SNPs) to identify genes responsible for
some common complex phenotypes for both discrete and
quantitative traits. A plenary lecture by Kari Stefansson
(deCODE Genetics, Reykjavik, Iceland) highlighted the
tremendous potential of this approach. Several examples
were discussed in which new genes have recently been iden-
tified using a combination of linkage and association analy-
sis approaches. One example is a locus on human
chromosome 8p12 that confers susceptibility to schizophre-
nia. Although nucleotide variation around the NRG1 gene
has been known to be associated with schizophrenia for the
past 4 years, the mechanism of action of the associated
SNPs, located in noncoding regions 5 to the gene, has
remained unclear. Recent evidence strongly suggests that
these variants might influence the level of NRG1 expression.
Stefansson suggested that many SNPs involved in the etiol-
ogy of complex phenotypes are likely to affect gene expres-
sion or splicing, and that these variants are under strong
selective pressure. A second, more recent, example presented
by Stefansson concerns the genetics of myocardial infarction,
where two genes involved in the production of the pro-
inflammatory molecule leukotriene B4 have been identified
as conferring an increased risk of this disorder. In particular,
a haplotype in the leukotriene A4 hydrolase gene (LTA4H)
was shown to confer a modest risk in caucasians (relative risk
compared with the general population (RR) = 1.16), but a
much higher risk in African Americans (RR approximately
3.5). The associated haplotype is likely to confer risk to
myocardial infarction through an upregulation of the
leukotriene pathway. As in the case of NGR1 in schizophre-
nia, quantitative rather than qualitative changes seem to be
important.
On the closely related topic of gene expression variation,
Harald Göring (Southwest Foundation for Medical Research,
San Antonio, USA) discussed the identification of genetic
determinants of gene expression, which are excellent candi-
dates for involvement in complex phenotypes. Göring and his
collaborators used the Illumina expression system (Sentrix
Human-6 gene bead arrays) to study the variation in expres-
sion of around 20,000 transcripts in 1,240 individuals of
Mexican-American origin. He reported that for most genes,
transcript levels vary significantly between individuals, and in
virtually all cases the variation in gene expression is geneti-
cally controlled (as determined by a significant heritability).
Quantitative linkage analysis was performed using the
SOLAR computer package, leading to the identification of cis-
regulatory loci in 15% of cases. Although similar studies have
been performed in the past, this study stands out in terms of
the increased statistical power to detect genetic effects.An interesting example of a genome-wide analysis for a
quantitative trait was presented by Arne Pfeufer (Technical
University Munich, Germany) in which the loci influencing
QT interval (the time the heart takes to recover from a ven-
tricular beat) were identified. Individuals with either too
high or too low QT interval are at risk of sudden cardiac
death. A whole-genome association study using the
Affymetrix 100K chip was carried out taking 100 individuals
with extreme QT values at each end of the spectrum.
Although no significantly associated SNPs were identified at
stage 1 of the study after correction for multiple testing, the
top 10 SNPs and additional candidate polymorphisms were
genotyped on a second cohort of people. This identified a
significant association of SNPs in the NOS1AP gene with QT
interval. The association was further validated in additional
cohorts from Germany and the US. Interestingly, the SNPs
with the highest association were located in a conserved
noncoding region 5 to the NOS1AP gene that has a potential
regulatory role.
Another area of exciting research concerns the genetics of
infectious diseases in human populations. Adrian Hill
(Oxford University, UK) reviewed the major advances in the
field, such as the discovery of polymorphisms within the
NRAMP1 gene that affect susceptibility to tuberculosis, and
the protective effect of polymorphic deletions within the
CCR5 gene against HIV infection. An interesting recent dis-
covery concerns the PTPN22 gene encoding a protein phos-
phatase, and in particular the Arg620 to RP variant. This is a
gain-of-function polymorphism that increases the protein’s
phosphatase activity in T cells and downregulates T-cell
responses. This variant has been previously associated with
a number of autoimmune diseases such as rheumatoid
arthritis and type 1 diabetes. Hill reported that the same
genetic variant is also associated with susceptibility to inva-
sive pneumococcal infection. This link between autoimmune
disease and susceptibility to infection suggests that other
alleles that predispose to autoimmune disorders might play
a role in modulating pathogen-host interactions. Strong
emphasis was also placed on the role of the Toll-like receptor
(TLR) signaling pathway in immune regulation and suscep-
tibility to disease. In particular, coding variants in the gene
for TLR2 have recently been shown to be associated to
increased susceptibility to tuberculous and lepromatous
leprosy in different populations. Other members of this
pathway are thus excellent candidates for further study in
both mouse and human systems for roles in modulating sus-
ceptibility to infectious disease.
The coming of age of comparative genomic
hybridization
The technique of comparative genomic hybridization (CGH)
was developed to detect subtle cytogenetic alterations
throughout the genome in a high-throughput manner.
Several emerging CGH technologies are now being used to
identify copy number alterations of increasingly smaller
regions. Joris Veltman (Radboud University, Nijmegen, The
Netherlands) has tested the ‘practical’ resolution of these new
CGH platforms (the Affymetrix 100K SNP array and the Nim-
blegen 385K CGH array) against that of a homemade 32K
array based on bacterial artificial chromosome clones (BACs).
Not surprisingly he found that fewer BACs than oligos were
necessary for the automatic detection of an imbalance, as
these interrogate larger regions; however, with 10 times as
many points interrogated, the Nimblegen array reached a res-
olution of 64 kb, twofold and sixfold better than the resolu-
tion of the Affymetrix and BAC arrays, respectively.
Mental retardation and global developmental delay are
relatively common disorders, each having a prevalence of 2-
3% in the general population, with chromosome abnormali-
ties as the single most common cause. However, the
detection rate of chromosome abnormality in surveys of
severe mental retardation/global development delay is only
15-40% with traditional techniques. Reasoning that cryptic
rearrangements might be uncovered with higher-resolution
methods, a number of laboratories have assayed the DNA of
patients with idiopathic mental retardation for unbalanced
chromosomal rearrangements. Orsetta Zuffardi (University
of Pavia, Italy) presented results obtained with 227 DNAs,
while Martin Poot (University Medical Centre Utrecht, The
Netherlands) and Evan Eichler (University of Washington
School of Medicine, Seattle, USA) discussed their analysis of
208 and 291 DNAs, respectively. All found that approxi-
mately 12% of the samples showed de novo imbalances
ranging from 0.1 to 13 Mb in size. Using a 1 Mb resolution
homemade BAC array, Bernard Thienpont (University of
Leuven, Leuven, Belgium) has similarly analyzed a cohort of
patients with a congenital heart defect of unknown cause
and either global development delay and/or major malfor-
mations. He found that 18% of the cohort had genomic
rearrangements, of which 11% were relevant de novo
rearrangements. 
Only two recurrent rearrangements were identified by the
above laboratories. A deletion at 17q21.3 that could explain
as much as 1% of idiopathic mental retardation was identi-
fied by Eichler. Interestingly, this region was recently shown
to be under positive selection in the European population. A
400 kb duplication in the Xq28 band, which contains the
MECP2 locus, was unveiled by Zuffardi. In a separate study,
Guy Froyen (Flanders Interuniversity Institute for Biotechnol-
ogy, Leuven, Belgium) found a duplication of the same
MECP2-containing region in a family with severe mental
retardation, and subsequently identified three more patients
with a similar dosage imbalance. Even though the duplications
in different individuals with mental retardation are not of the
same length (ranging from 7 to 50 genes), a comparison of the
new results with the literature showed that the minimal dupli-
cated region associated with mental retardation includes a set
of six genes comprising MECP2. The contribution of MECP2
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tion. A third recurrent rearrangement in people with mental
retardation was recently reported in the literature (a
microdeletion on 2q23.1-q23.2 in 3 out of 161 patients).
These reports emphasize the fact that some interstitial aneu-
somies (that is, the deletions or duplications within chromo-
some arms) might turn out to be relatively frequent. Zuffardi
also presented the results of an analysis of DNAs of patients
carrying apparently balanced reciprocal translocations or
complex rearrangements, and found that a large proportion
of them, 70% and 90%, respectively, also carried previously
unidentified insertions and/or deletions. In the case of the
translocations, imbalances were detected at the breakpoints
and elsewhere in the genome at approximately equal rates.
This suggests that care should be exercised when investigat-
ing apparently balanced rearrangements, which ideally
require a higher-resolution assessment of potential gains or
losses of genetic material.
In addition to genomic imbalances that result in pathological
phenotypes, a large number of copy-number polymorphisms
(CNPs) not associated directly with a phenotype are being
identified and studied. For example, Zuffardi reported more
than 200 large segments (0.1 to 2 Mb) present in different
copy numbers in healthy individuals, while Poot noted copy-
number variation in 333 autosomal loci. These loci seemed
not to be associated with G-bands (late replicating; A/T-rich
DNA) or R-bands (early replicating; G/C-rich DNA), but
were often flanked by segmental duplications. Eichler
reported similar numbers - 257 new CNPs in 344 normal
samples - and demonstrated Mendelian transmission of
some of these CNPs, where the number of copies of a locus
in an individual was either the sum or the average of the
number of copies identified in their parents. The heritability
calculated for 25 common CNPs was approximately 100%.
In addition, many CNPs are known to be in strong linkage
disequilibrium with flanking SNPs, suggesting that they are
mostly ancient polymorphisms rather than recurrent events.
Lisenka Vissers (Radboud University, Nijmegen, The Nether-
lands) focused her attention on 12 known CNPs present in at
least 5% of the population, and measured their copy numbers
in 309 individuals of Dutch, Finnish, Turkish, Indonesian and
Pygmy descent by multiplex ligation-dependent probe ampli-
fication (MLPA). A third of these CNPs showed no variation
in this sample, suggesting that the CNP databases might be
polluted by false positives. Other CNPs showed moderate
to extensive variation, and many were identified in all the
ethnic groups studied. Eichler noted that his team found
few population-specific CNPs. However, Vissers found that
the median number of copies was variable in different
ethnic groups. 
Over the next year we expect to see a dramatic increase in the
number and quality of whole-genome association studies,
with the identification of many functional polymorphisms
associated with common complex traits. It will be interesting
to see how many of these polymorphisms are localized in
coding compared with noncoding regions. We anticipate that
the next big challenge will be the development of statistical
methods able to dissect interactions between different vari-
ants as well as environmental effects. Another major hurdle
will be understanding the possible role of CNPs in complex
phenotypes, and we look forward to hearing about progress
in this and other fields at next year’s meeting. 
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
http://genomebiology.com/2006/7/8/324                                         Genome Biology 2006, Volume 7, Issue 8, Article 324 Deutsch and Reymond  324.3
Genome Biology 2006, 7:324